Syndax Pharmaceuticals Inc short interest in 2023
In 2023, Syndax Pharmaceuticals Inc's disclosed short interest ran from 9.06% of shares outstanding on 13 Jan 2023 to 12.04% on 29 Dec 2023, a change of +2.98 percentage points. The year's high was 15.25% on 15 Nov 2023 and its low 8.14% on 15 Jun 2023, averaging 10.92% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.64 days on 31 Aug 2023. Full history: Syndax Pharmaceuticals Inc.
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 9.06% (13 Jan 2023)
- End of year
- 12.04% (29 Dec 2023)
- Change
- +2.98 pp
- High
- 15.25% (15 Nov 2023)
- Low
- 8.14% (15 Jun 2023)
- Average
- 10.92%
- Highest days to cover
- 11.64 (31 Aug 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 9.06% | 5.96 | |
| 31 Jan 2023 | 9.12% | 8.43 | |
| 15 Feb 2023 | 9.16% | 8.98 | |
| 28 Feb 2023 | 9.95% | 10.17 | 10-K filed, results (8-K) |
| 15 Mar 2023 | 11.27% | 7.62 | |
| 31 Mar 2023 | 12.67% | 7.19 | |
| 14 Apr 2023 | 11.42% | 7.37 | |
| 28 Apr 2023 | 10.83% | 10.65 | |
| 15 May 2023 | 9.28% | 7.57 | 10-Q filed, results (8-K) |
| 31 May 2023 | 9.04% | 6.15 | |
| 15 Jun 2023 | 8.14% | 4.90 | |
| 30 Jun 2023 | 8.35% | 5.84 | |
| 14 Jul 2023 | 8.62% | 11.05 | |
| 31 Jul 2023 | 9.57% | 8.10 | |
| 15 Aug 2023 | 10.31% | 9.48 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 10.01% | 11.64 | |
| 15 Sep 2023 | 10.93% | 6.77 | |
| 29 Sep 2023 | 10.92% | 4.10 | |
| 13 Oct 2023 | 12.23% | 2.84 | |
| 31 Oct 2023 | 14.33% | 4.66 | |
| 15 Nov 2023 | 15.25% | 7.06 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 14.69% | 9.71 | |
| 15 Dec 2023 | 14.84% | 3.70 | |
| 29 Dec 2023 | 12.04% | 5.48 |
See also: Syndax Pharmaceuticals Inc's full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.